Dr. Collamore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1120 Polaris Pkwy
Ste 110
Columbus, OH 43240Phone+1 614-797-0600Fax+1 614-259-0610
Education & Training
- Ohio University Heritage College of Osteopathic Medicine in AthensClass of 2019
Certifications & Licensure
- FL State License 2023 - Present
- ND State License 2023 - 2027
- GA State License 2023 - 2027
- AK State License 2024 - 2026
- OH State License 2022 - 2026
- PA State License 2024 - 2026
- RI State License 2024 - 2026
- American Board of Family Medicine Family Medicine
- Join now to see all
Clinical Trials
- GGT and Uric Acid to Predict Gestational Diabetes Mellitus Start of enrollment: 2021 Jun 21
Roles: Contact
Publications & Presentations
PubMed
- 281 citationsPhase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid CancerElaine T. Lam, Matthew D. Ringel, Richard T. Kloos, Thomas W. Prior, Michael V. Knopp
Journal of Clinical Oncology. 2010-05-10 - 32 citationsG3139 (Genasense) in patients with advanced merkel cell carcinoma.Manisha H. Shah, Kimberly A. Varker, Minden Collamore, James A. Zwiebel, Daniel G. Coit
American Journal of Clinical Oncology. 2009-04-01 - 409 citationsPhase II Trial of Sorafenib in Metastatic Thyroid CancerRichard T. Kloos, Matthew D. Ringel, Michael V. Knopp, Nathan Hall, Mark A. King
Journal of Clinical Oncology. 2009-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: